HS-kbio

Mesima

Pharmacological Effects

Strengthen Body’s
Natural Defense System

Immune system is more than just a shield
— it’s a sophisticated internal army designed to detect, target, and eliminate threats like viruses, bacteria, and abnormal cells. But with modern stress, pollution, and aging, this natural defense can weaken, leaving your body vulnerable.

That’s where immune-supporting strategies like immunotherapy come into play. By enhancing the performance and activity of key immune cells—such as T cells, B cells, macrophages, and natural killer (NK) cells—immunotherapy helps your body fight off threats more effectively, including abnormal or cancerous cells.

Mesima, with its scientifically studied bioactive compounds, is designed to support this very process. By naturally activating and boosting immune cells, it helps reinforce your internal defenses—without the harsh side effects of traditional treatments like chemotherapy or radiation.

If you’re looking to stay resilient in today’s world, a strong immune system isn’t just a benefit—it’s a necessity.

Mesima: Natural Support for Cancer Care

Modern cancer treatments like chemotherapy and radiation can take a serious toll on the body—damaging organs, weakening immunity, and causing debilitating side effects like nausea, hair loss, and fatigue. While these therapies aim to fight cancer, they often leave the body defenseless.

That’s where Mesima steps in. As a powerful immunomodulatory supplement, Mesima helps restore balance to the immune system, reactivating weakened organs and boosting the body’s natural ability to defend itself. It not only reduces the side effects of conventional treatments but also supports immune recovery after surgery or intensive therapies.

Mesima’s ability to supercharge key immune cells

Research shows that Mesima can double the activity of Natural Killer (NK) cells, triple the function of T cells, and boost B cell antibody production by an astonishing 129 times. It even enhances macrophage activity up to fivefold—arming your body’s first responders in the fight against abnormal cells.

By naturally activating these cancer-fighting immune cells, Mesima helps suppress tumor growth and spread—without the harsh side effects of synthetic treatments. It’s a smart, science-backed ally for anyone seeking a gentler path to resilience during cancer care.

(홍남두, 유익동등이 발표한 Int. J. imunopharmacology (1996년) 및
 정경수 등이 발표한 Arch. Pharm. Res.(1993년) 자료에서 발췌 )

Naturally Power Your Immune System Against Cancer

Mesima helps your body detect and fight abnormal cells — without the side effects.

Not all cells follow the rules. Cancer cells defy the body’s natural limits, multiplying rapidly and invading healthy tissues. This loss of control is what makes them so dangerous—and so persistent.

Thankfully, your immune system is more capable than you think. When properly activated, it can recognize cancer cells as threats and eliminate them at the source. The challenge is sending the right signal.

Mesima supports this intelligent immune recognition. It enhances your body’s ability to distinguish harmful cancer cells from healthy ones, encouraging a targeted immune response that disrupts tumor growth naturally—without harming your body in the process.

In animal studies, Mesima showed promising results: reduced tumor size, extended lifespan, and most importantly, no signs of the toxicity seen in chemotherapy. It helps restore your internal balance while giving your body the tools to defend itself—gently and effectively.

Mesima Boosts Survival — Even Alongside Chemotherapy

Based on findings by Hong Nam-Doo & Kim Hwan-Mook (Immunopharmacology, 1999)

Post-implantation treatment (Therapeutic effect)

Mesima administered for 12 days after B16F10 implantation.

Pre-implantation treatment (Preventive effect)

Mesima administered for 7 days before and 12 days after B16F10 implantation.

Days after B16F10 implantation

(X-axis label for therapeutic timeline)

Days after B16F10 implantation

(X-axis label for preventive timeline)

Mesima was tested alongside low-dose chemotherapy — using only 10% and 30% of the standard Adriamycin dose
— to evaluate combined effects on immune response and tumor suppression

In a series of animal studies, researchers tested the effects of Mesima on mice implanted with cancer cells.

The results were promising: mice that received Mesima showed fewer side effects compared to those treated with chemotherapy alone. In fact, some experienced reduced tumor growth and lived longer—indicating not only better treatment outcomes, but also an improved quality of life.

When Mesima was combined with a low dose of the chemotherapy drug Adriamycin (ADR), survival rates increased significantly compared to using ADR alone. Even with much smaller doses of chemotherapy, the combination approach delivered better results—supporting the immune system while reducing toxicity.

These findings suggest that Mesima may help the body fight cancer more gently, making it a valuable complement to conventional treatment, especially for those seeking options with fewer side effects.

Mesima Enhances Lung Cancer Defense — Backed by Research

Shown to suppress tumor growth and prevent metastasis in human lung cancer models.

Based on studies by Hong Nam-Doo & Kim Hwan-Mook, Immunopharmacology (1999)

Inhibition of Human Lung Cancer (NCI-H23) Growth by Mesima and Adriamycin (ADR)

Prevention of Lung Cancer Metastasis
by Mesima and Adriamycin (ADR)

This study focused on human lung cancer cells (NCI-H23) and examined how Mesima, alone or in combination with the chemotherapy drug Adriamycin (ADR), affects tumor growth and metastasis.

The results were encouraging. While chemotherapy alone offered some benefit in slowing cancer spread, its effect was limited and depended on dosage. However, the groups that received Mesima alone or Mesima combined with ADR showed significantly stronger suppression of tumor growth and cancer metastasis.

These findings suggest that Mesima may provide valuable support in lung cancer treatment—enhancing the body’s natural defenses while reducing the need for higher doses of harsh chemotherapy. For patients and families concerned about side effects and long-term outcomes, this research offers real hope for more balanced, integrative care.

Helps regulate immune-related metabolic conditions like diabetes and chronic inflammation.

Today’s fast-paced lifestyle, combined with chronic stress and lack of exercise, has led to a sharp rise in metabolic conditions—commonly known as lifestyle diseases. These include obesity, diabetes, cardiovascular issues, and autoimmune-related skin conditions like eczema.

Much of this begins with a weakened immune system, often caused by external stressors and environmental factors. As immune function declines, the body becomes more vulnerable to chronic inflammation and metabolic imbalances.

One of the most impactful findings in recent research is Mesima’s potential role in regulating **Type 1 Diabetes (IDDM)**. This form of diabetes is caused by the immune system mistakenly attacking insulin-producing beta cells in the pancreas. Studies suggest that Mesima may help **modulate immune activity**, reducing autoimmune damage and supporting blood sugar regulation.

In this context, Mesima is not just an immune booster—it’s a biological modulator that can help **prevent and manage lifestyle-related diseases**. By strengthening internal balance, it may contribute to a healthier, more resilient body—and ultimately, a better quality of life.

Clinically Supported for Type 1 Diabetes (IDDM)

Immune System Enhancement

Biological Response Modulator (BRM)

Blood Glucose Regulation Effect of Mesima

Korean Patent Application No.: 2000-7137 PCT International Application No.: PCT/KR00/00897

Mesima Supports Healthy Blood Sugar — Naturally

Age of NOD Mice (weeks)